PTPRC and liver disorder: To investigate the functional effects of nizatidine on liver immune cells, we isolated CD45+ leukocytes from liver tissues of patients with advanced liver disease and HCC, and treated the immune cell population with nizatidine or vehicle control (Fig. 6b and Supplementary Fig. 15).